| CAT # | Inoa Huahana | wehewehe |
| CPD100594 | TT15 | ʻO TT15 kahi agonist o ka GLP-1R. |
| CPD100593 | VU0453379 | ʻO VU0453379 kahi CNS-penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM) |
| CPD100592 | PF-06882961 | ʻO ka PF-06882961 he agonist hiki ke loaʻa i ka waha o ka glucagon-like peptide-1 receptor (GLP-1R). |
| CPD100591 | PF-06372222 | ʻO PF-06372222 kahi mea liʻiliʻi-mole kino allosteric modulator (NAM) o ka glucagon receptor (GCGR). Hiki ke kōkua ka poʻe kūʻē o GCGR i ka mālama ʻana i ka maʻi maʻi maʻi type 2 no ka mea e hoʻoponopono lākou i nā pae glucose plasma ma o ka hoʻohaʻahaʻa ʻana a i ʻole ka hoʻolohi ʻana i ka hana glucose hepatic ma o ka hōʻailona ʻana i loko o ke ake, ka ʻiʻo maʻemaʻe o ka ʻōpū, ka puʻupaʻa, ka lolo, a me ka ʻiʻo adipose. ʻO PF-06372222 kekahi mea kūʻē no ka glucagon-like peptide-1 receptor GLP-1R, ka mea e pale ai i ka huna ʻana o ka glucagon a me ka huna ʻana o ka insulin i hilinaʻi i ka glucose a hiki ke pāʻani i ka hoʻokuʻu ʻana i ka hormonal e alakaʻi ana i ke kaumaha a me ka hopohopo. Ma ka hoʻololi ʻole ʻana i ka GLP-1R, hiki i ka PF-06372222 ke mālama i ka maʻi diabetes type 2 a me ke kaumaha a me ka hopohopo. |
| CPD100590 | NNC0640 | ʻO NNC0640 kahi modulator allosteric maikaʻi ʻole o ka glucagon-like peptide-1 receptor (GLP-1R). |
| CPD100589 | HTL26119 | ʻO HTL26119 kahi mea kūʻē allosteric hou o ka glucagon-like peptide-1 receptor (GLP-1R). |
